ALGS - Aligos Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $20. This is a potential upside of $-49.97 (264.3%) from yesterday's end of day stock price of $5.49.

Aligos Therapeutics 's activity chart (see below) currently has 5 price targets and 12 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.5% with an average time for these price targets to be met of 197.83 days.

Highest price target for ALGS is $20, Lowest price target is $20, average price target is $20.

Most recent stock forecast was given by MICHAEL YEE from UBS on 07-Jan-2026. First documented stock forecast 10-Nov-2020.

Best performing analysts who are covering ALGS - Aligos Therapeutics :

Eric Joseph Yasmeen Rahimi Michael Yee Tyler Van Buren Ed Arce

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Jan-2023

$20

$13.34 (200.30%)

$75

8 months 15 days ago
(07-Jan-2026)

1/4 (25%)

$10.35 (107.25%)

41

Buy

$70

$65.52 (1462.50%)

$70

1 years 5 months 22 days ago
(30-Mar-2025)

0/2 (0%)

$61.75 (748.48%)

Buy Since 17-May-2024

$7

1 years 11 months 29 days ago
(24-Sep-2024)

3/5 (60%)

$-5.6 (-44.44%)

119

Hold

$6

$-6.68 (-52.68%)

$12

4 years 6 months 7 days ago
(14-Mar-2022)

3/3 (100%)

$3.55 (144.90%)

634

Buy Since 08-Jul-2021

$47

$39 (487.50%)

5 years 2 months 14 days ago
(08-Jul-2021)

1/1 (100%)

$-364.25 (-88.57%)

274

Show more analysts

Please expand the browser size to see the chart

What is ALGS (Aligos Therapeutics ) average time for price targets to be met?

On average it took 198 days for the stock forecasts to be reached, with an average price target met ratio of 57.5%.

Which analyst most recently updated their price target on ALGS (Aligos Therapeutics )?

Michael Yee

Which analyst has the current lower performing score on ALGS (Aligos Therapeutics ) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on ALGS (Aligos Therapeutics )?

Michael Yee works at UBS and has 3 price targets and 7 ratings on ALGS

Which analyst is the currently most bullish on ALGS (Aligos Therapeutics )?

Ed Arce with the highest potential upside of $65.52

Which analyst is the currently most reserved on ALGS (Aligos Therapeutics )?

Eric Joseph with the lowest potential downside of -$6.68

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?